Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 494961 - 494980 out of 495900 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
USA | (L01FF01) nivolumab | OPDIVO QVANTIG | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbCompany |
USA | (L01FF03) durvalumab | IMFINZI 120MG INJ | 120MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01FF03) durvalumab | IMFINZI 120MG INJ | 120MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01FF03) durvalumab | IMFINZI 500MG INJ | 500MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01FF03) durvalumab | IMFINZI 500MG INJ | 500MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01FF09) tislelizumab | TEVIMBRA 10MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Esophageal Squamous Cell Carcinoma | BeiGeneUSA,Inc. |
USA | (L01FF09) tislelizumab | TEVIMBRA 10MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Esophageal Squamous Cell Carcinoma | BeiGeneUSA,Inc. |
USA | (L01FF10) retifanlimab | ZYNYZ 25MG/ML INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Merkel Cell | IncyteCorporation |
USA | (L01FF10) retifanlimab | ZYNYZ 25MG/ML INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Merkel Cell | IncyteCorporation |
USA | (L01FX06) dinutuximab beta | UNITUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
USA | (L01FX06) dinutuximab beta | UNITUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
USA | (L01FX20) tremelimumab | IMJUDO 20MG/ML INJ | 1.25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01FX20) tremelimumab | IMJUDO 20MG/ML INJ | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01FX20) tremelimumab | IMJUDO 20MG/ML INJ | 1.25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01FX20) tremelimumab | IMJUDO 20MG/ML INJ | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01FX31) zolbetuximab | VYLOY 300MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Esophageal Neoplasms | AstellasPharmaU.S.,Inc. |
USA | (L01XC) monoclonal antibodies | OPDIVO QVANTIG | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbCompany |
USA | (L01XK01) olaparib | LYNPARZA 100MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01XK01) olaparib | LYNPARZA 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01XK01) olaparib | LYNPARZA 100MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | ASTRAZENECAPHARMACEUTICALSLP |